LIST OF BINDING INTERFACES for query 'PROTEASOME SUBUNIT BETA TYPE-2' in category 'PROTEIN NAME'

(Click on the 'Details' column to view details on interfaces and similar patterns of amino acids)
Click on the 'View' column to view patterns on the structural viewer)

PDB	Ligand	Drug	Indication	Macromolecule/ Organism	Pfam	Binding_Interfaces (View)	Details
4qvp	BO2	Bortezomib (DB00188)	Bortezomib is a proteasome inhibitor used to treat multiple myeloma in patients who have not been successfully treated with at least two previous therapies.	PROTEASOME SUBUNIT BETA TYPE-2; PROTEASOME SUBUNIT BETA TYPE-3 (Saccharomyces cerevisiae)	Pr_beta_C Proteasome	4QVP_H_BO2H301  4QVP_K_BO2K301  4QVP_N_BO2N201	Details
4qvp	BO2	Bortezomib (DB00188)	Bortezomib is a proteasome inhibitor used to treat multiple myeloma in patients who have not been successfully treated with at least two previous therapies.	PROTEASOME SUBUNIT BETA TYPE-1; PROTEASOME SUBUNIT BETA TYPE-2 (Saccharomyces cerevisiae)	Pr_beta_C	4QVP_H_BO2H301  4QVP_K_BO2K301  4QVP_N_BO2N201	Details
5d0s	3BV	Carfilzomib (DB08889)	Carfilzomib is a proteasome inhibitor used either alone or in conjunction with a chemotherapy regimen to treat patients with relapsed or refractory multiple myeloma.	PROTEASOME SUBUNIT BETA TYPE-2; PROTEASOME SUBUNIT BETA TYPE-3 (Saccharomyces cerevisiae (strain atcc 204508 / s288c))	Pr_beta_C Proteasome	5D0S_H_3BVH301  5D0S_K_3BVK301  5D0S_N_3BVN201	Details
5d0s	3BV	Carfilzomib (DB08889)	Carfilzomib is a proteasome inhibitor used either alone or in conjunction with a chemotherapy regimen to treat patients with relapsed or refractory multiple myeloma.	PROTEASOME SUBUNIT BETA TYPE-1; PROTEASOME SUBUNIT BETA TYPE-2 (Saccharomyces cerevisiae (strain atcc 204508 / s288c))	Pr_beta_C	5D0S_H_3BVH301  5D0S_K_3BVK301  5D0S_N_3BVN201	Details
PDB	Ligand	Drug	Indication	Macromolecule/ Organism	Pfam	Binding_Interfaces (View)	Details

[["4qvp","BO2","Bortezomib (DB00188)","Saccharomyces cerevisiae","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","Pr_beta_C;Proteasome"],["4qvp","BO2","Bortezomib (DB00188)","Saccharomyces cerevisiae","PROTEASOME SUBUNIT BETA TYPE-1;PROTEASOME SUBUNIT BETA TYPE-2","Pr_beta_C"],["5d0s","3BV","Carfilzomib (DB08889)","Saccharomyces cerevisiae (strain atcc 204508 \/ s288c)","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","Pr_beta_C;Proteasome"],["5d0s","3BV","Carfilzomib (DB08889)","Saccharomyces cerevisiae (strain atcc 204508 \/ s288c)","PROTEASOME SUBUNIT BETA TYPE-1;PROTEASOME SUBUNIT BETA TYPE-2","Pr_beta_C"]]